Asana Recovery

Addiction and Recovery Blog

SUBSTANCE ADDICTION AMONG ACADEMICS

SUBSTANCE ADDICTION AMONG ACADEMICS

Substance addiction is a disease that can affect anyone, regardless of their intelligence or success. Perhaps nothing illustrates this better than the number of influential academics who have struggled with drug and alcohol

Read More »
Asana Recovery Center

FDA APPROVES NEW WITHDRAWAL MEDICATION

The Food and Drug Administration (FDA) has recently approved the first non-opioid medication designed to treat the symptoms of substance withdrawal. The medication, Lofexidine, will be sold under the brand name Lucemyra and

Read More »
SUBSTANCE ADDICTION AMONG ACADEMICS

SUBSTANCE ADDICTION AMONG ACADEMICS

Substance addiction is a disease that can affect anyone, regardless of their intelligence or success. Perhaps nothing illustrates this better than the number of influential academics who have struggled with drug and alcohol

Read More »
Asana Recovery Center

FDA APPROVES NEW WITHDRAWAL MEDICATION

The Food and Drug Administration (FDA) has recently approved the first non-opioid medication designed to treat the symptoms of substance withdrawal. The medication, Lofexidine, will be sold under the brand name Lucemyra and

Read More »